NCT05570097

Brief Summary

This Study study compared standard therapy (multimodal and regional analgesia) versus a novel approach (Cryoanalgesia combined with bilateral erector spine plane block and multimodal analgesia) in subjects undergoing minimal invasive modyfied Nuss procedure (thoracoscopy).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 28, 2022

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

September 29, 2022

Completed
7 days until next milestone

First Posted

Study publicly available on registry

October 6, 2022

Completed
4 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 10, 2022

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 10, 2022

Completed
Last Updated

March 28, 2023

Status Verified

March 1, 2023

Enrollment Period

12 days

First QC Date

September 29, 2022

Last Update Submit

March 27, 2023

Conditions

Keywords

nuss procedureERAScryolesiacryoanalgesia

Outcome Measures

Primary Outcomes (1)

  • The worse pain occurence during first 24 hours after operation

    Numeric pain score. Range from 0 to 10.

    up to 24 hours after operation

Secondary Outcomes (8)

  • Analgesic consumption post operation

    Postoperative days 0, 1, 2, 3, 4, 5,6, as well as months 1 and 3

  • Thoracic hypo-aesthesia occurence

    up to 24 hours after operation

  • Assessment of sleeping quality

    Postoperative days 1, 2, 3, 4, 5 ,6

  • Postoperative nausea and vomiting (PONV) occurence

    Postoperative days 1, 2, 3, 4, 5 ,6

  • Residual wound or chest pain occurence

    Postoperative months 1, 3

  • +3 more secondary outcomes

Study Arms (2)

"the before" group

NO INTERVENTION

Control group as a standard therapy in Poland (regional analgesia: intrapleural or bilateral erector spine plane block added to multimodal analgesia).

"the after" group

EXPERIMENTAL

During modyfied Nuss thoracoscopy the intraoperative Cryolesia of at least 5 intercostal nerves added to regional analgesia: bilateral erector spine plane block and multimodal therapy.

Device: intercostal nerves cryoanalgesia

Interventions

Intraoperative Cryolesia of at least 5 intercostal nerves added to regional analgesia: bilateral erector spine plane block and multimodal therapy.

"the after" group

Eligibility Criteria

Age10 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Patients undergoing pectus excavatum repair with modyfied minimal invasive thoracoscopic NUSS technique
  • aged 10 years or above 10
  • informed consent signed for cryoanalgesia

You may not qualify if:

  • Age of 9 years or below
  • Refuse to receive cryoanalgesia or regional analgesia as primary pain relief
  • Any contraindication to cryoanalgesia
  • Difficult follow-up for geographical reasons and/or impossibility by the patient to understand how to perform self-measurements

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Pomeranian Medical University

Szczecin, 71-252, Poland

Location

Related Publications (1)

  • Graves CE, Moyer J, Zobel MJ, Mora R, Smith D, O'Day M, Padilla BE. Intraoperative intercostal nerve cryoablation During the Nuss procedure reduces length of stay and opioid requirement: A randomized clinical trial. J Pediatr Surg. 2019 Nov;54(11):2250-2256. doi: 10.1016/j.jpedsurg.2019.02.057. Epub 2019 Mar 17.

MeSH Terms

Conditions

Funnel Chest

Condition Hierarchy (Ancestors)

Bone Diseases, DevelopmentalBone DiseasesMusculoskeletal DiseasesMusculoskeletal AbnormalitiesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Officials

  • Jowita Biernawska, MD PhD

    Pomeranian Medical Universitet Szczecin

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SEQUENTIAL
Model Details: Before - after study: First: control group as a standard treatment in Poland, review, then: interventional group
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

September 29, 2022

First Posted

October 6, 2022

Study Start

September 28, 2022

Primary Completion

October 10, 2022

Study Completion

December 10, 2022

Last Updated

March 28, 2023

Record last verified: 2023-03

Data Sharing

IPD Sharing
Will share

We invite others researchers to collaboration as multicenter study.

Shared Documents
STUDY PROTOCOL
Time Frame
up to 12 months from the beginning of the study
Access Criteria
by contact to Principal Investigator

Locations